Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
The healthcare stock's elevated valuation bakes in high expectations, leaving little room for error.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.